Allgenesis Biotherapeutics, Inc.

About

Allgenesis, a clinical stage biotech company focused on discovery and development of small molecules and biologics for ophthalmological diseases. Their clinical stage pipeline includes a first-in-class Fc-fusion protein for DME and wAMD, a multi-tyrosine kinase inhibitor for pterygium, and a topical eye drop being developed for dry eye with a novel first-in-class MoA.